0001742362-19-000003.txt : 20190924 0001742362-19-000003.hdr.sgml : 20190924 20190924165627 ACCESSION NUMBER: 0001742362-19-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190924 DATE AS OF CHANGE: 20190924 EFFECTIVENESS DATE: 20190924 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iKOR Labs Inc. CENTRAL INDEX KEY: 0001742362 IRS NUMBER: 814255494 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-349536 FILM NUMBER: 191111353 BUSINESS ADDRESS: STREET 1: 2840 WILDERNESS PLACE STREET 2: SUITE G CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 3035066476 MAIL ADDRESS: STREET 1: 2840 WILDERNESS PLACE STREET 2: SUITE G CITY: BOULDER STATE: CO ZIP: 80301 D 1 primary_doc.xml X0708 D LIVE 0001742362 iKOR Labs Inc. 2840 WILDERNESS PLACE SUITE G BOULDER CO COLORADO 80301 3035066476 COLORADO None None Corporation true 2016 Mark Fleming 9227 E Lincoln Ave, 200-406 Lone Tree CO COLORADO 80124 Executive Officer Director Craig Martin Sweeney 2840 Wilderness Place Suite G Boulder CO COLORADO 80301 Executive Officer Other Health Care Decline to Disclose 06b false 2019-09-09 false true false 0 300000 50000 250000 false 2 0 0 0 true If revenues are not sufficient to pay the salaries of Company employees (including directors/officers), offering proceeds reserved for working capital will be used to supplement the payment of such amounts. false iKOR Labs Inc. MARK FLEMING Mark Fleming CEO 2019-09-24